8 results
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... INCRETIN AGENTS • GLP ... - Prevents GLP ... #Management #pharmacology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Insulin Lifestyle ... Sulfonylureas GLP ... SGLT2 inhibitors
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
classes of type-2 diabetes ... Loss + - SGLT-2 inhibitors ... Weight Loss ++ - GLP ... Weight Gain ++ - Insulin ... weightgain #comparison #pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... , GLP-1 receptor ... α-glucosidase inhibitor ... #Medications #pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... Summary Mechanisms ... normally inactivates GLP ... #Pharmacology # ... Summary #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... Summary Mechanisms ... glucose-dependent insulin ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... -> Stimulates Insulin ... will stimulate insulin ... Renal #Dosing #Pharmacology ... #Management #Diabetes
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
and Management Summary ... sedimentation rate, insulin ... leukocytosis, psychiatric ... monoamine oxidase inhibitors ... apparent type 2 diabetes